Katja Strohfeldt Selected Research

(1,2- di(cyclopentadienyl)- 1,2- di(4- N,N- dimethylaminophenyl)ethanediyl)titanium dichloride

3/2006	Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
11/2005	In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katja Strohfeldt Research Topics

Disease

7	Neoplasms (Cancer) 06/2008 - 11/2005
3	Renal Cell Carcinoma (Grawitz Tumor) 03/2007 - 11/2005
2	Kidney Neoplasms (Kidney Cancer) 06/2008 - 03/2006
1	Thrombosis (Thrombus) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Breast Neoplasms (Breast Cancer) 03/2007
1	Colonic Neoplasms (Colon Cancer) 03/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2007
1	Ascites 03/2006
1	Mesothelioma 11/2005

Drug/Important Bio-Agent (IBA)

5	titanoceneIBA 06/2008 - 11/2005
4	Cisplatin (Platino)FDA LinkGeneric 03/2007 - 11/2005
4	Titanocene YIBA 03/2007 - 11/2005
4	TitaniumIBA 03/2006 - 11/2005
3	AgarIBA 03/2007 - 11/2005
2	MetalsIBA 06/2008 - 11/2005
2	(1,2- di(cyclopentadienyl)- 1,2- di(4- N,N- dimethylaminophenyl)ethanediyl)titanium dichlorideIBA 03/2006 - 11/2005
1	FlavonoidsIBA 01/2017
1	chrysinIBA 01/2017
1	RutheniumIBA 01/2017
1	fulveneIBA 06/2008
1	LigandsIBA 03/2006
1	SolventsIBA 03/2006
1	A-factor (Streptomyces)IBA 11/2005
1	Pharmaceutical PreparationsIBA 11/2005
1	Indicators and Reagents (Reagents)IBA 11/2005

Therapy/Procedure

1	Therapeutics 01/2017